Cyprus University of Technology   Report issue

Academic/Hospital Phase 1 Phase 2
Founded: Limassol Cyprus (2004)

Organization Overview

First Clinical Trial
2011
NCT01465308
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Angelos Kassianos | Cyprus University of Technology | Cyprus University of Technology Department of Nursing | Cyprus University of Technology (Nursing Department) | Hematological Clinic - Nicosia General Hospital | Nicosia General Hospital

Active Ingredients

Drugs in Phase 2 Trials (1)

honey (2 trials)

Drugs in Phase 1 Trials (2)

epoetin (Epogen) (1 trial)

lactoferrin (1 trial)

Drugs in Other Trials (3)

henna (1 trial)

panthenol (1 trial)

thyme (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 1)

Head and Neck Neoplasms (Phase 2)

Mucositis (Phase 2)

Stomatitis (Phase 2)

Xerostomia (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 6